Perineural Administration of Botulinum Toxin for Chronic Pain Management: A Narrative Review
Pain Research and Management · 2026-01 · 2026 (1)
DOI: 10.1155/prm/6539538 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pain Research and Management, online erschienen am 19.03.2026. Verfasst von Théo Belaise und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service D'anesthésie-Réanimation, Hôpitaux Universitaires De Strasbourg, Strasbourg, France, chru-strasbourg.fr. Hauptthemen laut MEDLINE: Chronic Pain, Botulinum Toxins, Neuralgia, Pain Management. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Neuropathic pain occurs as a direct consequence of a lesion or a disease affecting the somatosensory system. Because of the limited therapeutic arsenal, it is difficult to treat. Nevertheless, pain relief has been demonstrated in multiple clinical trials treating neuropathic pain patients with subcutaneous or intradermal administrations of botulinum toxin. However, this type of administration route shows limits; for example, the painful area may be too large for subcutaneous administration, or administration discomfort would be intolerable for direct injection into the painful area. For these reasons, alternative routes have been investigated, including the perineural one.
Objective
In the present review, we critically assess currently available clinical studies on perineural botulinum toxin administration for chronic pain treatment. We also discuss its possible underlying mechanisms and compare it to those of subcutaneous botulinum toxin administration.
Results
Studies demonstrated that perineural injection of botulinum toxin is an interesting alternative for the treatment of chronic pain, both for reducing pain intensity and improving quality of life. In addition to few reported side effects, compared to other pharmacological interventions, its strength also lies in its long‐lasting effects.
Conclusion
Despite promising results, the limited available literature cannot recommend this route of administration over others. More significant results and randomized controlled clinical trials are needed to support with confidence this route of administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service D'anesthésie-Réanimation, Hôpitaux Universitaires De Strasbourg, Strasbourg, France, chru-strasbourg.fr.
- Institut Des Neurosciences Cellulaires Et Intégratives (INCI), Centre National De La Recherche Scientifique (CNRS), Strasbourg, France, cnrs.fr.
- Centre D'Evaluation Et Traitement De La Douleur, Hôpitaux Civils de Colmar, Colmar, France.
ORCID-Profile: Mélanie Kremer, Yohann Bohren
Zitieren
APA
Belaise, T., Kremer, M., Poulain, B., Yalcin, I., & Bohren, Y. (2026). Perineural Administration of Botulinum Toxin for Chronic Pain Management: A Narrative Review. Pain Research and Management, 2026(1). https://doi.org/10.1155/prm/6539538
Vancouver
Belaise T, Kremer M, Poulain B, Yalcin I, Bohren Y. Perineural Administration of Botulinum Toxin for Chronic Pain Management: A Narrative Review. Pain Research and Management. 2026;2026(1). doi:10.1155/prm/6539538
BibTeX
@article{Belaise2026,
author = {Belaise, Théo and Kremer, Mélanie and Poulain, Bernard and Yalcin, Ipek and Bohren, Yohann},
title = {Perineural Administration of Botulinum Toxin for Chronic Pain Management: A Narrative Review},
journal = {Pain Research and Management},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/prm/6539538}
}
EUVIMED